|
⚲
|
| Keyboard |
| Hanley Rochelle
✚
|
|
|---|---|
| CIK # | 0001614595 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001614595] | |
| 4 | [0001614595] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Viking Therapeutics Inc | |
| Hanley Rochelle |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2016-05-04 | Tax withheld | 10,595 | $1.31 | 13,879 |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2016-03-04 | Grant | 35,250 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2015-05-04 | Disposed to issuer | 158,453 | ||
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2015-05-04 | Tax withheld | 7,308 | $9.49 | 69,353 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2015-05-04 | Grant | 70,000 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2015-05-04 | Grant | 30,000 | $0.00 |